Discure Technologies
Not specified, Israel· Est.
Discure creates a minimally invasive implant to regenerate degenerated spinal discs and alleviate chronic low‑back pain.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Discure creates a minimally invasive implant to regenerate degenerated spinal discs and alleviate chronic low‑back pain.
SpineOrthopedic
Technology Platform
A minimally invasive, implantable bio‑electronic device that restores intervertebral disc fluid dynamics to promote regeneration and alleviate chronic back pain.
Opportunities
Expansion into cervical disc disease and other synovial joints, combined with a growing demand for minimally invasive, value‑based spine therapies.
Risk Factors
Regulatory approval timelines, reimbursement uncertainty, and competition from established surgical and biologic spine solutions.
Competitive Landscape
Discure competes with traditional spinal fusion, disc replacement, and biologic injection therapies, differentiating itself through a reversible, outpatient bio‑electronic implant that aims to regenerate disc tissue rather than replace it.